To evaluate the correlation between exercise capacity and hemoglobin in pediatric patients with end-stage renal disease (ESRD) treated with automated peritoneal dialysis (APD) and hemodialysis.
Design
Prospective case-control study and retrospective review.
Setting
Dialysis summer camp and Children's Mercy Hospital exercise laboratory.
Participants
Prospective evaluation conducted with 14 patients (9 males, mean age 14.5 ± 2.5 years) who received either home APD (5 patients) or in-center hemodialysis (9 patients), and 8 healthy age-matched controls. Retrospective data derived from 10 children (7 males, mean age 12.3 ± 3.3 years), all of whom received APD.
Intervention
Maximal treadmill evaluation conducted with each patient and control. The hemoglobin value of each patient was also assessed.
Main Outcome Measures
Comparison of the following data generated during treadmill protocol: peak heart rate, blood pressure, oxygen saturation, treadmill time, oxygen consumption (VO2), ventilation (Ve), oxygen consumption at anaerobic threshold (VO2 AT), and respiratory exchange ratio.
Results
The hemoglobin value of the current patient group (12.8 ± 1.6 g/dL) was significantly greater than the previously studied patients (10.5 ± 1.1 g/dL) (p = 0.001). Treadmill time, VO2, and VO2 AT were significantly lower in both groups of dialysis patients compared to the control subjects (p < 0.05). No differences were noted in any of these variables when comparing these two groups of dialysis patients only.
Conclusion
The exercise capacity of pediatric dialysis patients is significantly poorer than that of healthy children, an outcome apparently related to factors other than normalization of the hemoglobin value.
JohansenK.L., ChertowG.M., NgA.V., MulliganK., CareyS., SchoenfeldP.Y.Physical activity levels in patients on hemodialysis and healthy sedentary controls.Kidney Int2000; 57: 2564–70.
2.
PainterP., Messer-RehakD., HansonP., ZimmermanS.W., GlassN.R.Exercise capacity in hemodialysis, CAPD, and renal transplant patients.Nephron1986; 42: 47–51.
3.
UlmerH.E., GrienerH., SchulerH.W., ScharerK.Cardiovascular impairment and physical working capacity in children with chronic renal failure.Acta Paediatr Scand1978; 67: 43–8.
4.
BlakeC., CoddM.B., CassidyA., O'MearaY.M.Physical function, employment and quality of life in end-stage renal disease.J Nephrol2000; 13: 142–9.
5.
MerkusM.P., JagerK.J., DekkerF.W., BoeschotenE.W., StevensP., KredietR.T.Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. The NECOSAD Study Group.Am J Kidney Dis1997; 29: 584–92.
6.
JanzK.Physical activity and bone development during childhood and adolescence. Implications for the prevention of osteoporosis.Minerva Pediatr2002; 54: 93–104.
7.
LeonardM.B., ZemelB.S.Current concepts in pediatric bone disease.Pediatr Clin North Am2002; 49: 143–73.
8.
MayerG., ThumJ., CadaE.M., StummvollH.K., GrafH.Working capacity is increased following recombinant human erythropoietin treatment.Kidney Int1988; 34: 525–8.
9.
BaranyP., FreyschussU., PetterssonE., BergstromJ.Treatment of anaemia in haemodialysis patients with erythropoietin: Long-term effects on exercise capacity.Clin Sci (Lond)1993; 84: 441–7.
10.
McMahonL.P., McKennaM.J., SangkabutraT., MasonK., SostaricS., SkinnerS.L.Physical performance and associated electrolyte changes after haemoglobin normalization: A comparative study in haemodialysis patients.Nephrol Dial Transplant1999; 14: 1182–7.
11.
BaranyP., PetterssonE., Konarski-SvenssonJ.K.Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.Nephrol Dial Transplant1993; 8: 426–32.
12.
NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000.Am J Kidney Dis2001; 37(1 Suppl 1): S182–238.
WaradyB.A., SabathR.J., SmithC.A., AlonU., HellersteinS.Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis.Pediatr Nephrol1991; 5: 718–23.
15.
ReybrouckT., WeymansM., StijnsH., van der HauwaertL.G.Ventilatory anaerobic threshold for evaluating exercise performance in children with congenital left-to-right intracardiac shunt.Pediatr Cardiol1986; 7: 19–24.
16.
FroelicherV.F., MarcondesG.D.Manual of Exercise Testing.Chicago: Yearbook Medical; 1989.
17.
SinekN., SabathR., SotiropoulosG.A comparison of directly measured oxygen uptake to a predicted value and field performance in prepubescent boys.Pediatric Exercise Science1990; 2: 179.
18.
PateR., LonnettM.Terminology in exercise physiology. In: BlairS., PainterP., PateR., SmithL., TaylorC., eds. ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription.Philadelphia: Lea et Febiger; 1988: 37–9.
19.
CrockerP.R., BaileyD.A., FaulknerR.A., KowalskiK.C., McGrathR.Measuring general levels of physical activity: Preliminary evidence for the Physical Activity Questionnaire for Older Children.Med Sci Sports Exerc1997; 29: 1344–9.
20.
JohansenK.L.Physical functioning and exercise capacity in patients on dialysis.Adv Ren Replace Ther1999; 6: 141–8.
21.
PainterP.The importance of exercise training in rehabilitation of patients with end-stage renal disease.Am J Kidney Dis1994; 24(1 Suppl 1): S2–9.
PainterP., Messer-RehakD., HansonP., ZimmermanS.W., GlassN.R.Exercise capacity in hemodialysis, CAPD, and renal transplant patients.Nephron1986; 42: 47–5.
27.
BedaniP.L., VerzolaA., BergamiM., StabelliniG., GilliP.Erythropoietin and cardiocirculatory condition in aged patients with chronic renal failure.Nephron2001; 89: 350–3.
28.
MarradesR.M., RocaJ., CampistolJ.M., DiazO., BarberaJ.A., TorregrosaJ.V.Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.J Clin Invest1996; 97: 2092–100.
29.
LundinA.P., AkermanM.J., CheslerR.M., DelanoB.G., GoldbergN., SteinR.A.Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.Nephron1991; 58: 315–19.
30.
MorrisK.P., SharpJ., WatsonS., CoulthardM.G.Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.Arch Dis Child1993; 69: 580–6.
31.
ScigallaP.Effect of recombinant human erythropoietin treatment on renal anemia and body growth of children with end-stage renal disease. The European Multicenter Study Group.Contrib Nephrol1991; 88: 201–11.
32.
PainterP., MooreG., CarlsonL., PaulS., MyllJ., PhillipsW.Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life.Am J Kidney Dis2002; 39: 257–65.
ScharerK., SchmidtK.G., SoergelM.Cardiac function and structure in patients with chronic renal failure.Pediatr Nephrol1999; 13: 951–65.
37.
SmogorzewskiM., MassryS.G.Uremic cardiomyopathy: Role of parathyroid hormone.Kidney Int Suppl1997; 62: S12–14.
38.
KrullF., Schulze-NeickI., HatoppA., OffnerG., BrodehlJ.Exercise capacity and blood pressure response in children and adolescents after renal transplantation.Acta Paediatr1994; 83: 1296–302.
39.
PainterP.L., HectorL., RayK., LynesL., DibbleS., PaulS.M.A randomized trial of exercise training after renal transplantation.Transplantation2002; 74: 42–8.
40.
PainterP.Exercise after renal transplantation.Adv Ren Replace Ther1999; 6: 159–64.
41.
PierratosA.Daily hemodialysis: An update.Curr Opin Nephrol Hypertens2002; 11: 165–71.
42.
JohansenK.L., KaysenG.A., YoungB.S., HungA.M., da SilvaM., ChertowG.M.Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients.Am J Clin Nutr2003; 77: 842–6.
43.
HungA.M., ChertowG.M., YoungB.S., CareyS., JohansenK.L.Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis.J Ren Nutr2002; 12: 170–6.
44.
StenvinkelP., AlvestrandA.Inflammation in end-stage renal disease: Sources, consequences, and therapy.Semin Dial2002; 15: 329–37.
